Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Multiomic approach boosts disease prediction accuracy beyond traditional methods

Study highlights the significant enhancement in predicting common diseases like heart disease, diabetes, Alzheimer's, and prostate cancer by integrating polygenic risk scores (PRSs) and gut microbiome scores with conventional risk factors, showcasing the potential of multiomic approaches in personalized medicine.

26 Mar 2024

Men with advanced degrees and higher income more likely to receive better prostate cancer care

Men with advanced degrees and higher income are more likely to receive certain care and treatment for prostate cancer.

26 Mar 2024

Study explores the role of health care algorithms in racial and ethnic disparities

For years, it was harder for Black patients to secure a coveted spot on the national kidney transplant waitlist because a clinical algorithm was making Black patients appear healthier than they were.

26 Mar 2024

MUTYH gene mutation linked to increased risk of various solid tumors

A gene associated with colorectal cancer appears to also play a role in the development of other solid tumors, according to a study of over 350,000 patient biopsy samples conducted by researchers at the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins Bloomberg School of Public Health and Foundation Medicine.

25 Mar 2024

Special drug-pricing program boosts prostate cancer treatment adherence

Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at other hospitals, according to a study from researchers at the University of Michigan's Rogel Cancer Center and Institute for Healthcare Policy and Innovation.

20 Mar 2024

Enhancing the safety and efficacy of breast and ovarian cancer treatment

Some anti-cancer treatments not only target tumour cells but also healthy cells. If their effects on the latter are too strong, their use can become limiting.

20 Mar 2024

Study: 20,000 men may have missed prostate cancer diagnosis due to the COVID-19 pandemic

Prostate cancer diagnoses in 20,000 men could have been missed due to the COVID-19 pandemic, finds a new study from the University of Surrey and the University of Oxford.

18 Mar 2024

Researchers aim to create AI-driven model for early detection of lung cancer risk

...

18 Mar 2024

The efficacy of the Mediterranean diet on health outcomes in adults with cancer

A new study published in Nature explores the safety and benefits of this diet in adults with cancer, in addition to its feasibility in this population.

15 Mar 2024

New analysis sheds light on cancer incidence and mortality trends in the UK

Trends in cancer incidence and deaths in the United Kingdom (UK) among individuals aged between 35 and 69 years.

14 Mar 2024

Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer

A high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.

13 Mar 2024

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

Prostate cancer stands as a prevalent threat to men's health, ranking second in cancer-related deaths in the United States.

11 Mar 2024

Common prostate cancer test may leave black men at increased risk of overdiagnosis

A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave black men at increased risk of overdiagnosis.

29 Feb 2024

DiaCarta partners with OncoAssure for prostate cancer test commercialization

DiaCarta, Inc., a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in California, today announced that it has established a strategic collaboration with OncoAssure Ltd, an Irish medical diagnostics company headquartered at NovaUCD in Dublin.

27 Feb 2024

Study demonstrates a feasible way to expand germline genetic testing for cancer patients

A new University of Kentucky Markey Cancer Center study published in JCO Precision Oncology demonstrates a feasible way to expand germline genetic testing for patients with cancer.

27 Feb 2024

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.

21 Feb 2024

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Multiomic approach boosts disease prediction accuracy beyond traditional methods

Men with advanced degrees and higher income more likely to receive better prostate cancer care

Study explores the role of health care algorithms in racial and ethnic disparities

MUTYH gene mutation linked to increased risk of various solid tumors

Special drug-pricing program boosts prostate cancer treatment adherence

Enhancing the safety and efficacy of breast and ovarian cancer treatment

Study: 20,000 men may have missed prostate cancer diagnosis due to the COVID-19 pandemic

Researchers aim to create AI-driven model for early detection of lung cancer risk

The efficacy of the Mediterranean diet on health outcomes in adults with cancer

New analysis sheds light on cancer incidence and mortality trends in the UK

Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

Common prostate cancer test may leave black men at increased risk of overdiagnosis

DiaCarta partners with OncoAssure for prostate cancer test commercialization

Study demonstrates a feasible way to expand germline genetic testing for cancer patients

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

NIH-funded research enhances genetic testing for health equity

Selection, optimization, and validation of genetic tests for 10 common diseases

What factors are associated with recent prostate-specific antigen screening in transgender women?

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in